Happy New Year – 2016

It’s been an interesting year. When I started this site I really didn’t know what was going to happen… in most respects, it has exceeded my expectations. A Few Opening Remarks On a positive note, I genuinely felt support for the mission of trying to create a fresh dialogue around the quality and transparency of ASX-listed companies operating in this…

Starpharma Sensationalism

Really? REALLY? Yesterday Starpharma (ASX : SPL) announced that it had done some mouse models with a Herceptin-conjugated DEP dendrimer. It wasn’t peer reviewed data. It wasn’t an exhaustive pre-clinical package. It was just a one-off science experiment packaged up and served to retail investors as company propaganda. 20 mice. The company even states that…

Winds of Change

If I was talented enough regarding web design to make this page open up with the Scorpians whistling away “Wind of Change” in the background… I surely would. Having followed the “Moskva down to Gorky Park”  in the middle of winter on many occasions, I can only try and do my best to send a warm vibe…

Because an Emu Wouldn’t Fit in the Oven…

One of my great hopes for the Australian biosciences scene is that we get to a stage of market information quality that retail investors can read and use a critical assessment of a biotech stock, and actually take note rather than just get their knickers in a twist. It requires many ecosystem changes but if we want to…

Is Clinuvel Relevant?

I will state from the outset, I don’t like this company, but not for reasons that will dissuade most people from taking a look at the stock. It’s funny because I get a lot of flack for writing posts about baby ASX biopharma companies that I actually do sort of like. I do sort of…

The Future of Prescient?

I have to admit that Prescient Therapeutics (ASX : PTX) hasn’t particularly been on my radar, never really looked at it. With a market cap of $3m, I could probably be forgiven for this except for the fact that this forum is supposed to be about the Long Tail of the ASX, and PTX is pretty…